5.3 Pre-Existing Conditions, Waiting Periods, and Moratoriums

5.3 Pre-Existing Conditions, Waiting Periods, and Moratoriums

Quick Answer: The 90-day cancer moratorium is an essential anti-selection safeguard in Canadian critical illness policies. Under a 90-day cancer exclusion, a diagnosis or relevant signs, symptoms or investigations within that window can exclude the cancer benefit even if diagnosis occurs later. Future cancer and related-condition claims may also be excluded; remaining coverage and any premium adjustment follow the contract. Furthermore, under Canada's Genetic Non-Discrimination Act, insurers cannot require a genetic test or disclosure of results as an insurance condition. Collection, use or disclosure of results requires the individual’s written consent.

The 90-Day Cancer Moratorium (Cancer Exclusion Period)

Cancer is an insidious disease that frequently develops over months or years, often accompanied by early, subtle, non-specific physiological symptoms (such as unprovoked weight loss, chronic fatigue, suspicious cutaneous moles, or painless nodules). In the absence of strict contractual underwriting controls, an individual who notices an abnormal lump or receives an alarming preliminary blood panel would have an overwhelming incentive to purchase a $500,000 or $1,000,000 critical illness policy immediately prior to booking a specialist biopsy. This dynamic represents severe adverse selection (anti-selection).

To safeguard pool solvency and ensure fair pricing for all policyholders, CLHIA includes a 90-Day Cancer Moratorium Clause in its voluntary benchmarks. The issued policy specifies the applicable exclusion period and start date.

Contractual Mechanics of the 90-Day Clause

The moratorium begins on the latest of: the policy issue date, the policy effective date, or the date of any contractual policy reinstatement following a premium lapse. Under standard contract wording, coverage for cancer is entirely excluded if, within the first 90 consecutive days:

1. The insured receives a diagnosis of any cancer, including an early-stage cancer not eligible for the full benefit; OR
2. The insured experiences signs, symptoms, or undergoes medical consultations, laboratory tests, or diagnostic investigations that subsequently lead to a diagnosis of cancer, regardless of when the final histological diagnosis is officially established.

Repercussions When the Moratorium is Triggered

Apply the consequences stated in the issued policy:

• Cancer Benefit: No benefit is payable for the excluded cancer. A clause can also exclude future cancer diagnoses, even a different cancer.
• Remaining Coverage: The contract may continue for other conditions, subject to its exclusions. Do not assume a cancer-related loss qualifies merely because it is claimed under another condition.
• Premiums: The moratorium itself does not promise a refund or a reduction in premiums. Apply any express premium-adjustment or cancellation right.
• Reporting: Report the diagnosis and related medical history within the contract’s deadline. For example, a six-month reporting clause can permit denial of cancer or cancer-related claims if information is not supplied; this is distinct from proving fraudulent misrepresentation.

Pre-Existing Condition Exclusion Clauses

Beyond the specific 90-day cancer moratorium, Canadian critical illness contracts incorporate broad Pre-Existing Condition Exclusion Clauses, particularly within simplified-issue or guaranteed-issue contracts that bypass fluid testing and attending physician statements.

For this worked model, assume a pre-existing-condition clause with a 24-month lookback and a 24-month post-issue exclusion period. Apply the actual clause and applicable statutory protection when reviewing a policy:

$\text{Pre-Existing Bar: Medical Consultation in Prior 24 Months} \longrightarrow \text{Diagnosis in Subsequent 24 Months} = \text{Claim Excluded}$

If, during the 24 months immediately preceding the policy effective date, the applicant:

• Sought medical advice, consulted a physician, or received specialized clinical treatment;
• Took prescription medications or underwent diagnostic examinations; or
• Exhibited clear objective symptoms that would cause an ordinarily prudent person to seek medical counsel;

and as a direct or indirect consequence of that underlying health condition, the insured suffers a covered critical illness within the first 24 months of policy coverage, no benefit is payable. For this assumed clause, the post-issue time limit controls when the general exclusion ends; remaining healthy is not a separate condition. A specifically named exclusion can continue beyond that period.

Moratorium vs. Pre-Existing Exclusions vs. Incontestability

LLQP candidates must distinguish between statutory incontestability, pre-existing condition clauses, and moratoriums:

Under the A&S two-year rule, non-fraudulent nondisclosure generally ceases to make the contract voidable after the applicable period. However, a claim for a loss incurred or disability beginning within the first two years can remain contestable after the second anniversary. Reinstatement representations have their own period. A valid named exclusion remains a boundary of coverage; incontestability does not turn an excluded condition into an insured one.

General Policy Exclusions

In addition to medical timing restrictions, CI policies can contain general exclusions. Apply the actual wording; common examples deny benefits if the critical illness results directly or indirectly from:

• Intentional Self-Inflicted Injuries: Self-mutilation or attempted suicide, regardless of whether the insured was sane or insane at the time of the act.
• Criminal Conduct: The insured's active participation in, or commission of, a criminal offense under the Criminal Code of Canada or foreign equivalent.
• War and Civil Insurrection: Specified war, combat or conflict-zone activities, as the policy defines them.
• Substance and Narcotics Abuse: Chronic alcoholism, liver cirrhosis secondary to chronic alcohol abuse, or voluntary ingestion of illicit narcotics, toxic substances, or prescription medications taken contrary to physician instructions.

The Canadian Genetic Non-Discrimination Act (Bill S-201)

In 2017, the Parliament of Canada enacted the Genetic Non-Discrimination Act (GNDA), which was subsequently upheld as constitutional by the Supreme Court of Canada in a landmark 2020 decision (Reference re Genetic Non-Discrimination Act). The legislation fundamentally transformed Canadian underwriting:

1. Ban on Mandatory Genetic Testing: It is a federal criminal offense for an insurance company to require an individual to undergo a genetic test as a condition of obtaining, continuing, or adjusting an insurance contract.
2. No Required Disclosure of Results: An insurer cannot require an individual to disclose genetic-test results as a condition of entering into or continuing an insurance contract or particular terms. It cannot refuse those contractual activities because the individual refuses to disclose results.
3. Written Consent for Results: Section 5 prohibits collecting, using or disclosing an individual’s genetic-test results without their written consent. Inadvertent access is not consent. This is separate from the prohibition on requiring a test or its results as an insurance condition.